The most important alkaloid is galantamine, which has been approved by the Food and Drug Administration (FDA) for the treatment of mild to moderate Alzheimer’s disease in research trials (AD) [46] because of its possible acetylcholine esterase-inhibiting activity [47]. Here, ACHE is linked to Alzheimer disease.